1. U.S. Food & Drug Administration. Precision medicine, September 27, 2018. https://www.fda.gov/medical-devices/in-vitro-diagnostics/precision-medicine
2. Accelerated approvals hit the target in precision oncology;Subbiah;Nat Med,2022
3. U.S. Food & Drug Administration Code of Federal Regulations Title 21§809.3(a). Definitions.
4. U.S. Food & Drug Administration Code of Federal Regulations Title 21§862. 1300 Follicle-Stimulating Hormone Test System.
5. U.S. Food & Drug Administration Code of Federal Regulations Title 21§866.5940. Autosomal recessive carrier screening gene mutation detection system.